Clinical trial NCT03656497: Classical Trigeminal Neuralgia and Sodium Channel Mutations
Official title: Classical Trigeminal Neuralgia and Sodium Channel Mutations
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Trigeminal Neuralgia
Keywords: genetic mutations, voltage gated sodium channels, phenotype,
Lead sponsor: Danish Headache Center
Sponsor class: OTHER
Collaborators: name: Maastricht University Medical Center
First posted: 2018-09-04
Enrollment: 33
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: OTHER
Sampling method: PROBABILITY_SAMPLE
Study population: Patients suffering from trigeminal neuralgia and has an onset of disease before the age of 42 and/or first-line relative with TN.

Brief summary: The most common cause of trigeminal neuralgia is considered to be a neurovascular contact. However, this etiological factor only seem to be present in half of the patient group. Thus the etiology of the other half is unknown.

Gain-of function genetic mutations in voltage gated sodium channels have been hypothesized as playing a role in the etiology of trigeminal neuralgia but it has yet to be confirmed. In recent years gain-of-function mutations have been identified as a causative factor in other pain-diseases presenting with trigeminal neuralgia phenotypic similarities.

Detailed description: The aim of this study was to indentify VGSC gene mutations, specifically SCN9A, SCN10A and SCN11A genes, in a group of well characterized trigeminal neuralgia patients.

Setting: The study will be conducted at The Danish Headache Center, Rigshospitalet - Glostrup, Denmark (inclusion of patients and written Informed Consent, patient interview, phenotyping/diagnosis, neurological examination, blood sample.

Departments of Neurology and Clinical Genomics of the Maastricht University Medical Center, Maastricht, the Netherlands: Targeted NG Sanger Sequencing

Eligibility criteria: 3.1. Inclusion Criteria

Subjects of both sexes with TN must meet the following inclusion criteria to be eligible for participation:

1. Patients must be able to give Signed Informed Consent prior to study entry
2. Patients fulfilling of the ICHD-3 beta diagnostic criteria for classical TN.1
3. Age 18 years or older.
4. Age at debut \< 42 years and/or confirmed first-line relative with TN.
5. Respond to sodium channel blockers with a 50% reduction of pain intensity evaluated by both the patient and the examining physician using the visual analog scale (VAS).

3.2. Exclusion Criteria

Subjects will be excluded if one of the following exclusion criteria is met:

1. Psychiatric or mental illness of physical condition that might interfere with the ability of the patients to fill in the Informed Consent and questionnaires.
2. History of herpes zoster in the distribution of the trigeminal nerve ipsilateral to pain, multiple sclerosis or a space-occupying lesion.
3. History indicative of painful posttraumatic trigeminal neuropathy such as previous trauma, surgery or radiation to the trigeminal nerve ipsilateral to pain.

Primary outcomes:
measure: Exploratory study of association between phenotype and genotype of trigeminal neuralgia
timeFrame: 1 day
Secondary outcomes:
Other outcomes:
Locations:
Study officials:
affiliation: Danish Headache Center
name: Lars Bendtsen, ass. prof.
role: STUDY_CHAIR
References: